Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Dear Editor,
We read with great interest in Pediatric Rheumatology the article by Schnappauf et al. [1] referred to the association of the homozygous variant p. Arg90His in NCF1 gene with early-onset interferonopathy. Whilst heterozygosity for the rare rs201802880 p.Arg90His variant of NCF1 had been associated previously with susceptibility to systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and Sjögren’s syndrome in adult patients [2], the authors nicely showed, through exome sequencing, the association of the homozygous Arg90His variant with interferonopathy appearing features of autoinflammation and autoimmunity, in a pediatric 5-year old female patient of Indian ancestry [1]. Gene expression analysis was conducted in peripheral blood by an elegant way and an interferon gene expression signature was detected, which was further supported by cytokine analyses of supernatants of cultured patient’s cells. Altogether, these findings suggested that the inflammatory disease developed in the patient was at least in part mediated by type I interferons. Interferonopathies are a group of autoinflammatory diseases characterized by excessive activation of type I interferon that leads to disturbances in immune function. Neutrophil cytosolic factor 1 (NCF1) is an essential component of the gene family encoding NOX2 that represents the phagocytic NADPH oxidase isoform complex, which is an enzyme response for one-electron reduction of molecular oxygen to superoxide [3]. The rs201802880 variant of NCF1, altering an arginine to histidine in a PX domain of the NCF1 protein, in humans leads to reduction-of-function of NADPH oxidase [4].
Anzeige
Prompted by the findings of Schnappauf et al. [1] and the fact that rs201802880 is a shared genetic factor involved in the development of various autoimmune diseases, we attempted to elucidate further the functional significance of the Arg90His variant by using a structural biology approach. The role of the highly conserved Arg90 present in a pocket of the p47phox PX Domain has been shown in the past to be the direct involvement in recognition of the polar heads of phosphoinositides [5]. By using the structure of the PX domain of p47phox (PDB code 1KQ6 and [6]) that exhibits a phosphoinositide-binding activity that is normally suppressed by interacting intramolecularly with the C-terminal SH3 domain we are showing here that the substitution of Arg90 (Fig. 1 A) to His (Fig. 1B) not only eliminates the direct electrostatic interactions of the p47phox domain with the phosphate groups (shift from 2.4 to 6 A shown with dashed lines) but also weakens the positive charge distribution on the molecular surface. In addition, the shorter His side chain creates an empty volume between the histidine imidazole group and the phosphate at a distance of 6 A causing either further conformational changes or rehydration of the molecular surface both leading to loss of the p47phox PX Domain to phospoinositide interaction. This is in agreement with the multidiscipline studies by Karathanassis et al. [7] and Ueyama et al. [8] showing respectively that the Arg90Ala and Arg90Lys mutations on the p47phox PX Domain decrease membrane affinities, resulting in longer membrane residence time due to disruption of their interaction with the cognate phospholipid ligand. The loss of the domain’s capacity to bind PI(3,4)P2 shows significant loss of translocation to the plasma membrane [5].
×
To our knowledge, this is the first study to evaluate the structural significance of the rs201802880 SNP causing the Arg90His mutation on the p47phox PX Domain. We conclude that this SNP modifies the function of the p47phox PX cytosolic subunit of neutrophil NADPH oxidase leading to affinity reduction to PtdIns(3,4)P2 caused by the loss of specific phosphoinositide headgroup interactions and affecting the p47phox translocation to the plasma membrane. This information would help to further interpret the findings of Schnappauf et al. [1] from the structural-functional point of view.
Declarations
Ethics approval and consent to participate
N/A.
Consent for publication
N/A.
Anzeige
Competing interests
The authors have declared no conflicts of interest.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Persistieren Sinusitisbeschwerden bei Kindern länger als zehn Tage, ist eine Antibiotikatherapie häufig gut wirksam: Ein Therapieversagen ist damit zu über 40% seltener zu beobachten als unter Placebo.
Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.
Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.
Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.
Update Pädiatrie
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.